Market News

Stifel Financial Has Trimmed Its Cara Therapeutics (CARA) Position; Weingarten Realty Investors (WRI) Sellers Decreased By 17.99% Their Shorts

Stifel Financial Corp decreased Cara Therapeutics Inc (CARA) stake by 42.27% reported in 2017Q3 SEC filing. Stifel Financial Corp sold 47,155 shares as Cara Therapeutics Inc (CARA)’s stock rose 14.02%. The Stifel Financial Corp holds 64,400 shares with $887,000 value, down from 111,555 last quarter. Cara Therapeutics Inc now has $467.28 million valuation. The stock increased 3.32% or $0.46 during the last trading session, reaching $14.33. About 460,790 shares traded. Cara Therapeutics, Inc. (NASDAQ:CARA) has risen 206.00% since February 24, 2017 and is uptrending. It has outperformed by 189.30% the S&P500.

Weingarten Realty Investors (NYSE:WRI) had a decrease of 17.99% in short interest. WRI’s SI was 2.29M shares in February as released by FINRA. Its down 17.99% from 2.79M shares previously. With 672,700 avg volume, 3 days are for Weingarten Realty Investors (NYSE:WRI)’s short sellers to cover WRI’s short positions. The SI to Weingarten Realty Investors’s float is 1.91%. The stock increased 0.99% or $0.27 during the last trading session, reaching $27.68. About 1.41M shares traded or 86.92% up from the average. Weingarten Realty Investors (NYSE:WRI) has declined 15.79% since February 24, 2017 and is downtrending. It has underperformed by 32.49% the S&P500.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.76, from 1.61 in 2017Q2. It is negative, as 22 investors sold CARA shares while 31 reduced holdings. 20 funds opened positions while 25 raised stakes. 17.83 million shares or 4.68% less from 18.71 million shares in 2017Q2 were reported. Tci Wealth Advsrs accumulated 0% or 175 shares. 19,600 were reported by Td Asset Mngmt. State Board Of Administration Of Florida Retirement has invested 0% of its portfolio in Cara Therapeutics, Inc. (NASDAQ:CARA). Davenport Limited Company owns 14,111 shares. Deutsche Bank & Trust Ag holds 148,953 shares. Guggenheim Capital Ltd Com owns 108,958 shares or 0% of their US portfolio. Northern Tru holds 327,766 shares or 0% of its portfolio. Stifel invested 0% in Cara Therapeutics, Inc. (NASDAQ:CARA). Credit Suisse Ag has 0% invested in Cara Therapeutics, Inc. (NASDAQ:CARA). Federated Pa holds 0% of its portfolio in Cara Therapeutics, Inc. (NASDAQ:CARA) for 39,695 shares. Moreover, Susquehanna Int Llp has 0% invested in Cara Therapeutics, Inc. (NASDAQ:CARA). 26,370 were accumulated by Bankshares Of America De. Schwab Charles Investment Mngmt has 0% invested in Cara Therapeutics, Inc. (NASDAQ:CARA) for 39,117 shares. Millennium Ltd Co holds 0% or 19,381 shares. State Of Wisconsin Inv Board reported 0% in Cara Therapeutics, Inc. (NASDAQ:CARA).

Stifel Financial Corp increased Kla (NASDAQ:KLAC) stake by 8,201 shares to 76,480 valued at $8.11 million in 2017Q3. It also upped Mastec Inc (NYSE:MTZ) stake by 20,306 shares and now owns 35,910 shares. Cimarex Energy Co (NYSE:XEC) was raised too.

Analysts await Cara Therapeutics, Inc. (NASDAQ:CARA) to report earnings on March, 8. They expect $-0.40 EPS, up 50.62% or $0.41 from last year’s $-0.81 per share. After $-0.38 actual EPS reported by Cara Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 5.26% negative EPS growth.

Among 10 analysts covering Cara Therapeutics (NASDAQ:CARA), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cara Therapeutics had 24 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Scotia Capital on Thursday, November 24 with “Outperform”. The stock has “Buy” rating by Cantor Fitzgerald on Wednesday, November 4. H.C. Wainwright maintained it with “Buy” rating and $3000 target in Thursday, July 13 report. Piper Jaffray maintained the stock with “Buy” rating in Friday, August 4 report. The firm earned “Buy” rating on Friday, August 4 by H.C. Wainwright. The rating was maintained by Stifel Nicolaus on Tuesday, January 2 with “Buy”. The stock of Cara Therapeutics, Inc. (NASDAQ:CARA) earned “Buy” rating by Needham on Wednesday, June 21. The stock has “Buy” rating by H.C. Wainwright on Thursday, June 22. The stock has “Buy” rating by Canaccord Genuity on Friday, June 30. The stock of Cara Therapeutics, Inc. (NASDAQ:CARA) has “Buy” rating given on Thursday, October 13 by H.C. Wainwright.

Since January 24, 2018, it had 0 insider buys, and 4 selling transactions for $538,560 activity. On Thursday, February 15 the insider Menzaghi Frederique Ph.D. sold $45,060. CHALMERS DEREK T had sold 12,500 shares worth $187,500.

Among 8 analysts covering Weingarten Realty Investors (NYSE:WRI), 3 have Buy rating, 1 Sell and 4 Hold. Therefore 38% are positive. Weingarten Realty Investors had 20 analyst reports since August 14, 2015 according to SRatingsIntel. Zacks upgraded Weingarten Realty Investors (NYSE:WRI) rating on Thursday, August 27. Zacks has “Hold” rating and $36 target. On Thursday, December 14 the stock rating was upgraded by Boenning \u0026 Scattergood to “Neutral”. The stock of Weingarten Realty Investors (NYSE:WRI) earned “Hold” rating by SunTrust on Tuesday, October 24. Citigroup maintained Weingarten Realty Investors (NYSE:WRI) on Friday, August 14 with “” rating. The stock of Weingarten Realty Investors (NYSE:WRI) has “Hold” rating given on Wednesday, August 19 by Zacks. The firm has “Neutral” rating given on Friday, August 12 by Citigroup. The firm earned “Neutral” rating on Monday, October 30 by JP Morgan. The stock of Weingarten Realty Investors (NYSE:WRI) has “Neutral” rating given on Wednesday, April 27 by Citigroup. On Friday, April 21 the stock rating was initiated by Robert W. Baird with “Outperform”. The rating was maintained by Jefferies on Monday, June 19 with “Hold”.

Leave a Reply

Your email address will not be published. Required fields are marked *